Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care
Shah et al., The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(22)00412-X (preprint 9/22/2022)
https://c19early.org/shah5.html